Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain

Blood (2025) 146 (Supplement 1): 3077.

https://doi.org/10.1182/blood-2025-3077

Published: 2025

Journal Articles

Clinical characteristics, treatment strategies, and response patterns in evans syndrome: Initial analysis from the spanish resti cohort

Maria Eva Mingot, Elena Sebastián Pérez, Javier Bañon Soria, Daniel Martinez Carballeira, Isabel González-gascón-y-Marín, Reyes Jimenez Barcenas, Gonzalo Caballero Navarro, David Valcarcel, Maria Cristina Pascual Izquierdo

Blood (2025) 146 (Supplement 1): 1263.

https://doi.org/10.1182/blood-2025-1263

Published: 2025

Journal Articles

Early multi-immune modulation with rilzabrutinib in patients with primary ITP after first-line treatment failure: A phase 3b study (LUNA 4)

David Kuter, Waleed Ghanima, Nicola Cooper, Marie Luise Hütter-Krönke, Guillaume Moulis, Francesco Zaja, Maria Cristina Pascual Izquierdo, Howard Liebman, Sandhya Panch, Hisashi Kato, Matias Cordoba, Ahmed Daak, Maria Belen Rodriguez

Blood (2025) 146 (Supplement 1): 4827.

https://doi.org/10.1182/blood-2025-4827

Published: 2025

Journal Articles

Reproductive health in patients with primary immune thrombocytopenia (ITP) receiving rilzabrutinib: A subgroup analysis from the Phase 3 LUNA3 multicenter study

Michele Lambert, Nicola Cooper, Maria Cristina Pascual Izquierdo, Elisa Lucchini, Sylvain Audia, Huafang Wang, Yoshitaka Miyakawa, Meredith Foster, Maria Belen Rodriguez, Ahmed Daak, David Kuter

Blood (2025) 146 (Supplement 1): 3027.

https://doi.org/10.1182/blood-2025-3027

Published: 2025

Journal Articles

Switching ITP patients to avatrombopag from other TPO-ras: A real-world experience of the spanish ITP group (GEPTI).

Maria Cristina Pascual Izquierdo, Jose Maria Bastida, David Valcarcel, Blanca Sánchez González, Maria Eva Mingot, Mariana Canaro Hirnyk, Gerardo Aguilar Monserrate, Alicia Ortiz Lopez, Sara Carbonell, Sandra García Lázaro, Anna Martín Carrizosa, Carla Alonso Martinez, Patricia Alcalde Mellado, Begoña Pedrote Amador, Enma Serrasolses Aleman, María Remezal Serrano, Marta Canet Maldonado, Maria del Carmen Gomez Del Castillo, Maialen Lasa Elizalgue, Isabel González-gascón-y-Marín, Denis Zafra, Cristina Fernández Canal, Sonia Piernas Fontanilla, Laura Hernandez Vazquez, Eduardo Morales Espino, Teresa Cobo Rodriguez, Daniel Martinez Carballeira, Patricia Gonzalez Marugan, Estefania Bolaños Caderon, Gonzalo Caballero Navarro, Nuria Revilla-Calvo, Teresa Arquero-Portero, Marta Cervera, Manuel Rodriguez-Lopez, Javier Bañon Soria, Andres Ramirez Lopez, María Teresa Alvarez-Román

Blood (2025) 146 (Supplement 1): 1253.

https://doi.org/10.1182/blood-2025-1253

Published: 2025

Journal Articles

Review of the management of patients with immune thrombotic thrombocytopenic purpura with persistently low adamts-13 activity - a challenge beyond rarity.

Maria Eva Mingot, Inés Gómez Seguí, Maria Cristina Pascual Izquierdo, Faustino García-Candel, Denis Zafra, Lourdes Dominguez-Acosta, Saioa Zalba

Blood (2025) 146 (Supplement 1): 4887.

https://doi.org/10.1182/blood-2025-4887

Published: 2025

Journal Articles

A multicenter, randomized, open-label study of dexamethasone versus romiplostim plus dexamethasone as first line treatment in patients with newly diagnosed immune thrombocytopenia: Interim results of rodex study

Blood (2025) 146 (Supplement 1): 733.

https://doi.org/10.1182/blood-2025-733

Published: 2025

Journal Articles

Easix, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura

Blood (2025) 146 (Supplement 1): 6661.

https://doi.org/10.1182/blood-2025-6661

Published: 2025

Journal Articles

ADAMTS13 Activity Measurement Using a Chemiluminescence-Based Technique. Prospective Multicenter Comparative Study of the Spanish Apheresis Group (GEA)- Spanish Society of Hematology and Hemotherapy (SEHH)

Maria Cristina Pascual Izquierdo, Jorge Martínez Nieto, Maribel Diaz-Ricart, Marta Fernández Docampo, Ines Gomez Segui, Manuel Fernanadez-Villalobos, Rafel López del Amo, Patricia Martinho, Silvia Escribano-Serrat, Julia Martinez-Sanchez, ANA Belen MORENO Castaño, Toni Moscardo, Eva Mingot Castellano, Amanda Lopez Picado, Ramon Salinas Argente, Julio Del Rio Garma, Teresa Fidalgo

Blood (2024) 144 (Supplement 1): 2618.

https://doi.org/10.1182/blood-2024-200941

Published: 2024

Journal Articles

Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments

Blood (2024) 144 (Supplement 1): 3948.

https://doi.org/10.1182/blood-2024-201847

Published: 2024

Journal Articles

Epidemiology of Hereditary Thrombotic Thrombocytopenic Purpura (TTP) in Spain: Preliminary Results of a Study of the Spanish TTP Registry (REPTT)

Inés Gómez Seguí, Maria Cristina Pascual Izquierdo, Maria Eva Mingot, Amanda Lopez Picado, Guillermo Sanz, Javier de la Rubia, Ramon Salinas Argente, Julio Del Rio Garma

Blood (2024) 144 (Supplement 1): 3999.

https://doi.org/10.1182/blood-2024-203666

Published: 2024

Journal Articles

Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Adults with Previously Treated Immune Thrombocytopenia (ITP): A Phase 3, Placebo-Controlled, Parallel-Group, Multicenter Study (LUNA 3)

Blood (2024) 144 (Supplement 1): 5.

https://doi.org/10.1182/blood-2024-199718

Published: 2024

Journal Articles

Avespa Study: Effectiveness and Safety of Avatrombopag in Immune Thrombocytopenia (ITP). a Real-World Study of the Spanish ITP Group (GEPTI)

Blood (2024) 144 (Supplement 1): 713.

https://doi.org/10.1182/blood-2024-200861

Published: 2024

Journal Articles

Use of Steroids in Subjects with ITP in Spain: Duration and Toxicity

Blood (2024) 144 (Supplement 1): 1183.

https://doi.org/10.1182/blood-2024-201829

Published: 2024

Journal Articles

Unveiling Genetic Insights: Promises and Challenges of Next-Generation Sequencing in Diagnosing Inherited Thrombocytopenia

Marta Moreno Carnonell, Alicia Ortiz López, Pablo Silva, Diana Casares, Manuel Jorge Fernández Villalobos, Diego Ochoa Zemeño, Carolina Martinez-Laperche, Maria Cristina Pascual Izquierdo

Blood (2024) 144 (Supplement 1): 5420.

https://doi.org/10.1182/blood-2024-209676

Published: 2024

Journal Articles

Impact of Age on Hemostasis of Patients with Immune Thrombocytopenia

Elena Monzón Manzano, Maria Teresa Álvarez-Roman, Paula Acuña, Elena G Arias-Salgado, Raquel Ramírez Martín, Maria Cristina Pascual Izquierdo, Maria Isabel Rivas Pollmar, Monica Martin Salces, Waleed Ghanima, Víctor Jiménez-Yuste, Nora Butta

Blood (2023) 142 (Supplement 1): 1211.

https://doi.org/10.1182/blood-2023-185706

Published: 2023

Journal Articles

Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

Blood (2023) 142 (Supplement 1): 5429.

https://doi.org/10.1182/blood-2023-180970

Published: 2023

Journal Articles

Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)

Blood (2023) 142 (Supplement 1): 2636.

https://doi.org/10.1182/blood-2023-179316

Published: 2023

Journal Articles

Caplacizumab As New Paradigm-Changing Therapy for Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (aTTP): Real-World Data from TTP Spanish Registry

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-136627

Published: 2020

Journal Articles

Long Term Discontinuation of Eltrombopag after Remission in Primary Immune Thrombocytopenia: 8-Year Follow-up Data from 15 Spanish Centers

Tomas Jose Gonzalez-Lopez, Fernando Fernandez-Fuertes, Maria Cristina Pascual Izquierdo, PhD MD, Isabel Caparros, Silvia Bernat, Carmen Pastoriza, Maria Paz Martínez-Badas, Pável E Olivera, MD, Gonzalo Caballero, MD, Jose Angel Hernandez-Rivas, MD PhD, Daniel Martínez-Carballeira, MD, Inmaculada Soto Ortega, Gloria Perez Segura, Isabel Regalado, Blanca Sánchez-González, Isidro Jarque, Luis Javier garcia Frade, MD, Miguel A. Sanz

Blood (2019) 134 (Supplement_1): 2352.

https://doi.org/10.1182/blood-2019-129274

Published: 2019

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain

Clinical characteristics, treatment strategies, and response patterns in evans syndrome: Initial analysis from the spanish resti cohort

Early multi-immune modulation with rilzabrutinib in patients with primary ITP after first-line treatment failure: A phase 3b study (LUNA 4)

Reproductive health in patients with primary immune thrombocytopenia (ITP) receiving rilzabrutinib: A subgroup analysis from the Phase 3 LUNA3 multicenter study

Switching ITP patients to avatrombopag from other TPO-ras: A real-world experience of the spanish ITP group (GEPTI).

Review of the management of patients with immune thrombotic thrombocytopenic purpura with persistently low adamts-13 activity - a challenge beyond rarity.

A multicenter, randomized, open-label study of dexamethasone versus romiplostim plus dexamethasone as first line treatment in patients with newly diagnosed immune thrombocytopenia: Interim results of rodex study

Easix, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura

ADAMTS13 Activity Measurement Using a Chemiluminescence-Based Technique. Prospective Multicenter Comparative Study of the Spanish Apheresis Group (GEA)- Spanish Society of Hematology and Hemotherapy (SEHH)

Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments

Epidemiology of Hereditary Thrombotic Thrombocytopenic Purpura (TTP) in Spain: Preliminary Results of a Study of the Spanish TTP Registry (REPTT)

Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Adults with Previously Treated Immune Thrombocytopenia (ITP): A Phase 3, Placebo-Controlled, Parallel-Group, Multicenter Study (LUNA 3)

Avespa Study: Effectiveness and Safety of Avatrombopag in Immune Thrombocytopenia (ITP). a Real-World Study of the Spanish ITP Group (GEPTI)

Use of Steroids in Subjects with ITP in Spain: Duration and Toxicity

Unveiling Genetic Insights: Promises and Challenges of Next-Generation Sequencing in Diagnosing Inherited Thrombocytopenia

Impact of Age on Hemostasis of Patients with Immune Thrombocytopenia

Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)

Caplacizumab As New Paradigm-Changing Therapy for Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (aTTP): Real-World Data from TTP Spanish Registry

Long Term Discontinuation of Eltrombopag after Remission in Primary Immune Thrombocytopenia: 8-Year Follow-up Data from 15 Spanish Centers

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only